Bayer’s BlueRock Therapeutics establishes European site for cell therapy innovation
Bayer AG announced that BlueRock Therapeutics LP (BlueRock), a clinical stage biopharmaceutical company and wholly-owned subsidiary of Bayer AG, has established a new site for cell therapy innovation on Bayer’s campus in Berlin, Germany. This move comes as part of the company’s focused grow ... > more